Position:Business Development Manager
Lynne Tucker is the Business Development Manager for the Diabetes Trials Unit. A Biochemistry graduate with a Postgraduate Diploma in Management Studies, Lynne has worked in clinical research for 20 years.
Having managed both UK and global trials and a translational research group, Lynne now focuses on facilitating new business in the Phase II to IV trial portfolio.
Effects of Acarbose on Cardiovascular and Diabetes Outcomes in Patients with Coronary Heart Disease and Impaired Glucose Tolerance: A Randomised Controlled Trial
Rury R Holman et al.
Lancet Diabetes Endocrinol. 2017;5:877-86
The effect of a brief action planning intervention on adherence to double-blind study medication, compared to a standard trial protocol, in the Atorvastatin in Factorial with Omega EE90 Risk Reduction in Diabetes (AFORRD) clinical trial: a cluster randomised sub-study
Andrew J. Farmer et al.
Diabetes Research and Clinical Practice 2016;120:56-64
Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes
M.A. Bethel et al.
Diabetic Medicine 2016;33:224-230
Evaluation of a Self-Administered Oral Glucose Tolerance Test
M. Angelyn Bethel et al.
Diabetes Care 2013;36:1483-1488
A self-administered oral glucose tolerance test
MA Bethel et al.
Diabetic Medicine 2012;2012 Sup 1:47
Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial
Holman RR et al.